Peptide InjectionsAI
Moderate evidence

Cardiogen

Peptide therapy: benefits, side effects, cost and protocols

C7H15NO3

161.2 g/mol / CID 10917
C7H15NO3

Cardiogen (Ala-Glu-Asp-Arg) is a short bioregulatory peptide targeting cardiac tissue. It is studied for its potential to normalize myocardial function, support cardiovascular health, and promote heart tissue repair.

ByChris Riley(CFA)|Updated

Sources: FDA / PubMed / ClinicalTrials.gov View

FDA status
Research Only Not currently approved for human use in the US. Available as a research compound. Not eligible for compounding.
Evidence
Moderate Evidence

Who Cardiogen is usually considered for

  • Cardiac tissue support
  • Cardiovascular function
  • Myocardial health
  • Age-related heart support
  • Limited human trials or strong preclinical

How Cardiogen works

Bioregulator peptide that may interact with gene promoter regions in cardiomyocytes, modulating expression of proteins involved in cardiac contractility and tissue maintenance.

Key studies

82 papers on PubMed / 60 human trials

  1. 01

    [Worsening in patients treated in acute stroke units--results of the Austrian Stroke Unit Registry]

  2. 02

    Ferrari J, Flamm-Horak A, Lischka-Lindner A et al

    Wien Med Wochenschr / Wien Med Wochenschr

  3. 03

    Diabetes, hypertension, cardioembolism, and large vessel disease predict early clinical worsening in stroke patients

  4. 04

    [Cardiomyopathy and ion channel diseases registry: the Szeged CardioGen Registry]

  5. 05

    Blazsó P, Kákonyi K, Forster T et al

    Orv Hetil / Orv Hetil

  6. 06

    Registry of 809 cardiomyopathy and ion channel disease patients with similar mortality/morbidity to literature

  7. 07

    [Investigation of insertion/deletion polymorphism of the ACE gene in stroke patients]

  8. 08

    Pongrácz E, Tordai A, Csornai M et al

    Ideggyogy Sz / Ideggyogy Sz

  9. 09

    ACE D/D polymorphism not independent stroke risk factor but associated with hyperlipidemia in young patients

  10. 10

    2011 investigation of internal contamination with radioactive strontium following rubidium Rb 82 cardiac PET scan

Cardiogen compound data

C7H15NO3
161.20 g/mol
10917 ↗
(3R)-3-hydroxy-4-(trimethylammonio)butanoate

Cardiogen questions

What is CARDIOGEN?

Cardiogen is a Khavinson bioregulator tripeptide (Ala-Glu-Asp) researched for cardiovascular tissue support and cardiac cell function in age-related decline.

How does CARDIOGEN work?

Bioregulator peptide that may interact with gene promoter regions in cardiomyocytes, modulating expression of proteins involved in cardiac contractility and tissue maintenance.

Is CARDIOGEN legal to buy?

CARDIOGEN is sold as a research chemical for laboratory use only. It is not approved for human use by the FDA. Regulations vary by jurisdiction.

Where can I buy CARDIOGEN?

CARDIOGEN is available as a research compound from verified online vendors. Always verify third-party testing before purchasing.

What category does CARDIOGEN belong to?

CARDIOGEN is primarily classified as a tissue repair & healing peptide. Peptides studied for their potential in wound healing, tendon/ligament repair, gut healing, and general tissue regeneration.

What are the research benefits of CARDIOGEN?

CARDIOGEN has been studied for: Cardiac tissue support, Cardiovascular function, Myocardial health, Age-related heart support. Khavinson bioregulator; cardiovascular/cardiac tissue focus.

Cardiogen in the news

News aggregated via Google News. Inclusion does not imply endorsement.

Considering Cardiogen?

The 2-minute quiz matches you with licensed providers who offer it. A clinician decides if it fits.

Take the quiz